Purchase Order 75N91019P00773

Award Date 9/16/19
Potential Completion Date 11/14/19
Potential Value $164K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Marshallton, DE 19808, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services, National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a firm fixed price purchase order to Agilent Technologies Inc. to procure one Agilent Seahorse XFe96 Analyzer for $203,939.10. The analyzer will be used by the NCI's Urologic Oncology Branch to study cellular metabolism and support ongoing cancer research. The contract does not have a set-aside designation. Agilent Technologies Inc. is a global leader in life sciences...
The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order contract to Agilent Technologies Inc. (Agilent) for the provision of a SEAHORSE XFE96 ANALYZER. The contract has a potential value of $205,093.00 and a completion date of January 21, 2024. Agilent is a global leader in life sciences, diagnostics, and applied chemical markets, providing laboratories worldwide with instruments, software, services, and...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $21,740.40 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division for a SERVICE AGREEMENT FOR THE SEAHORSE XFE96 ANALYZER. The prime contractor, Agilent Technologies Inc., is a subsidiary of Agilent Technologies, Inc. Agilent Technologies Headquarters Division. Place of performance will be in Rockville, MD. The period of performance is from...
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division to provide an AGILENT SEAHORSE XFE96 ANALYZER. The award, which did not have a set-aside designation, had a potential value of $149,781.75 and a completion date of August 22, 2017. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and...
This is a $149,984.51 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) to Agilent Technologies Inc. for the purchase of a Seahorse XFe96 Analyzer. The NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) procured this equipment without full and open competition, citing the need for continuity of ongoing research projects related to APOL1. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied markets,...
The National Cancer Institute (NCI), a civilian federal agency, awarded a $22,831.20 firm fixed price purchase order to Agilent Technologies Inc. for a service agreement to provide the Seahorse XFE96 Analyzer. This equipment is used for cellular bioenergetics research and will be delivered by July 31, 2025. Agilent, a global leader in life sciences instrumentation, has a long history of providing analytical equipment and services to various federal agencies through both prime and subcontracts....
This is a $169,152.75 firm fixed price purchase order contract awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency, to Agilent Technologies Inc. Customer Service And Sales Division. The contract is for a Seahorse XFe96 Analyzer, which is a specialized instrument used to measure the energy production pathways of live cells. The award was made on a sole source basis, as Agilent was determined to be the only vendor capable of meeting the agency's specific...
This is a firm fixed-price delivery order awarded by the National Heart Lung and Blood Institute, a civilian federal agency, to Agilent Technologies Inc. for maintenance services on a Seahorse XFE96 Analyzer. The contract has a ceiling value of $13,525.00 and an ultimate completion date of August 1, 2025. The award was not set aside and was competitively awarded. Agilent Technologies Inc. is a global manufacturer of advanced scientific instruments and laboratory equipment, and this award is part...
The Department of Health and Human Services National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $164,253.00 Firm Fixed Price Purchase Order to Agilent Technologies Inc. Customer Service And Sales Division on September 20, 2019. The order is for a SEAHORSE XFE96 ANALYZER 64 BIT and has a completion date of October 30, 2019. The equipment will be delivered to Bethesda, Maryland. Agilent Technologies Inc. is a global leader in life...
This is a $20,552.40 firm fixed-price purchase order awarded by the National Institute on Aging to Agilent Technologies Inc. for maintenance service on a Seahorse XFE96 Flux Analyzer, a specialized scientific instrument used in laboratory research. The contract has an ultimate completion date of August 31, 2026. Agilent Technologies Inc. is a global leader in life sciences and analytical instrumentation, providing advanced equipment and services to numerous federal agencies. This contract...

This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Agilent Technologies Inc. to procure an Agilent Seahorse XFe96 Analyzer, a specialized instrument for measuring cellular metabolism. The contract has a firm fixed price of $164,253.00 and does not have a set-aside designation. The Agilent Seahorse XFe96 Analyzer will be used to support research activities at the National Cancer Institute. Agilent Technologies Inc. has a history of providing analytical instrumentation and services to various federal agencies including the NIH, FDA, CDC, and others.

Generated 3/24/24, 7:02 AM